Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study

BACKGROUND: The prognosis of non-small cell lung cancer (NSCLC) patients with central nervous system (CNS) metastasis is poor. The treatment for CNS metastasis could prolong the overall survival of NSCLC patients. We aimed to investigate the prognostic factors of Chinese NSCLC patients with CNS meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiaoxing, Chen, Minjiang, Liu, Xiaoyan, Shi, Yuequan, Liang, Hongge, Zhou, Qing, Zhao, Jing, Pan, Ruili, Zhong, Wei, Xu, Yan, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090435/
https://www.ncbi.nlm.nih.gov/pubmed/35558520
http://dx.doi.org/10.3389/fonc.2022.879554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090435/
https://www.ncbi.nlm.nih.gov/pubmed/35558520
http://dx.doi.org/10.3389/fonc.2022.879554

Ejemplares similares